Document is current
Any future updates will be listed below
-
Authors
Magnussen, Helge M. http://orcid.org/0000-0002-1104-2973
Ahmed, Syed F. http://orcid.org/0000-0003-1033-2538
Sibbet, Gary. J.
Hristova, Ventzislava A.
Nomura, Koji
Hock, Andreas K.
Archibald, Lewis J.
Jamieson, Andrew G.
Fushman, David
Vousden, Karen H.
Weissman, Allan M.
Huang, Danny T. http://orcid.org/0000-0002-6192-259X
- License Information
-
More Information
Article History
Received: 9 October 2019
Accepted: 27 March 2020
First Online: 29 April 2020
Competing interests
: K.H.V. is on the Board of Directors and shareholder of Bristol Myers Squibb, a shareholder of GRAIL Inc. and on the Science Advisory Board (with stock options) of PMV Pharma, RAZE Therapeutics, and Volastra Therapeutics. She is also on the SAB of Ludwig Cancer. K.H.V. is a co-founder and consultant of Faeth Therapeutics, funded by Khosla Ventures. She has been in receipt of research funding from Astex Pharmaceuticals and AstraZeneca and contributed to CRUK Cancer Research Technology filing of Patent Application WO/2017/144877.
